Coronary vasodilating action of dobutamine in patients with idiopathic dilated cardiomyopathy
- 1 May 1993
- journal article
- Published by Elsevier BV in American Heart Journal
- Vol. 125 (5), 1329-1336
- https://doi.org/10.1016/0002-8703(93)91003-w
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- β-Adrenergic contractile reserve as a predictor of clinical outcome in patients with idiopathic dilated cardiomyopathyAmerican Heart Journal, 1992
- Atrial natriuretic factor attenuates the pulmonary pressor response to hypoxiaJournal of Applied Physiology, 1988
- Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. Dose-response relationships, correlation with circulating catecholamines, and effect of phosphodiesterase inhibition.JCI Insight, 1988
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982
- Novel Double-Isotope Technique for Enzymatic Assay of Catecholamines, Permitting High Precision, Sensitivity and Plasma Sample CapacityClinical Science, 1981
- Dobutamine in chronic ischemic heart failure: Alterations in left ventricular function and coronary hemodynamicsThe American Journal of Cardiology, 1981
- The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure.Cell Metabolism, 1977
- Influence of dobutamine on hemodynamics and coronary blood flow in patients with and without coronary artery diseaseThe American Journal of Cardiology, 1976
- Coronary vascular sympathetic beta-receptor innervationAmerican Journal of Physiology-Legacy Content, 1976
- Effects of Dobutamine on Left Ventricular Performance, Coronary Dynamics, and Distribution of Cardiac Output in Conscious DogsJCI Insight, 1974